A carregar...
Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face
Background. For large basal cell carcinomas (BCCs) of the head and neck, definitive surgery often requires extensive resection and reconstruction that may result in prolonged recovery and limited cosmesis. Vismodegib, a small-molecule inhibitor of the hedgehog pathway, is approved for advanced and m...
Na minha lista:
| Publicado no: | Case Rep Oncol Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609426/ https://ncbi.nlm.nih.gov/pubmed/26504605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/827608 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|